197 - Frontier AI as Foreign Policy, Medicare Expands Weight-Loss Drugs, and Health Systems Face the Outpatient Reckoning

Vic and Marcus discuss slowing U.S. job growth, Meta's move into AI cloud infrastructure, record venture funding driven by AI, and what those trends mean for the technology sector. They examine Medicare coverage for weight loss drugs, proposed CMS changes affecting hospitals, Medicaid work requirement lawsuits, and the continued shift of care away from hospitals. They also cover major healthcare advances, including expanded gene therapy for children with sickle cell disease, AI-powered drug discovery partnerships, and the first FDA-approved Treg cell therapy. The episode concludes with the record-low U.S. death rate, stablecoin adoption, blockchain tokenization, and the growing AI competition between the U.S. and China.
Story Lineup

1 — In This Economy
3:47 - Story 1: U.S. labor market cools sharply: June jobs report shows only 57,000 positions added [WSJ]

7:14 - Story 2: Meta Is Planning a Cloud Business to Sell AI Computing Power [Bloomberg]

2 — VC Deal Review
10:30 - Story 1: Global startup investment surges to record $510B in H1 2026 as AI exits accelerate [Crunchbase News]

12:40 - Story 2: Beeline raises $126M Series A extension on heels of $300M launch, bolsters autoimmune pipeline [Fierce Biotech]

3 — Policy
14:15 - Story 1: Medicare begins covering GLP-1 weight-loss drugs for seniors at $50/month out-of-pocket starting July 1 [WSJ]

15:17 - Story 2: CMS targets 340B drug discount program and site-neutral pay in 2027 outpatient rule overhaul [Becker's Hospital Review]

21:20 - Story 3: Twenty-six states sue Trump administration over Medicaid work requirements rule implementation [Healthcare Dive]

4 — Health Payors
28:59 - Story 1: Evernorth commits $100M through 2028 to AI-powered specialty pharmacy program expansion [MedCity News]

5 — Health Systems
30:28 - Story 1: 10-year outlook: outpatient volumes set to grow 20% while inpatient discharges rise just 7%, reshaping hospital economics [Becker's Hospital Review]

32:45 - Story 2: Large health system EHR migrations collapse 40% year-over-year as Epic dominance and vendor delays lock in incumbency [Becker's Hospital Review]

6 — Pharma & Novel Therapies
37:55 - Story 1: FDA expands Vertex's Casgevy CRISPR gene therapy to children as young as 2 with sickle cell disease [Becker's Hospital Review]

39:36 - Story 2: Takeda partners with Insilico on AI drug discovery platform worth up to $600M across multiple therapeutic areas [WSJ]

41:21 - Story 3: Orca Bio's Tregzi becomes first FDA-approved regulatory T cell therapy for graft-versus-host disease [MedCity News]

7 — About Health & Us / The Clinician's Voice
43:45 - Story 1: U.S. Death Rate Falls to Its Lowest Point on Record [WSJ]

8 — Web3
46:52 - Story 1: Open USD stablecoin launch backed by Visa, Mastercard, and Google challenges USDC/USDT incumbents [Decrypt Media]

49:41 - Story 2: Ondo launches SEC-compliant tokenized ETF and equities with Ethereum settlement, signaling institutional crypto infrastructure maturation [The Block]

9 — The AI Tracker
51:28 - Story 1: Health systems pivot from proving AI efficacy to scaling implementations; inflection point for health tech adoption [Becker's Hospital Review]

56:53 - Story 2: Anthropic unveils Claude Science AI workbench for pharma research execution ahead of anticipated IPO [MedCity News]

59:52 -Story 3: New Chinese AI model matches Anthropic Claude performance; likely to reshape White House AI policy overhaul [WSJ]

1:08:23 - Story 4: OpenAI proposes handing Trump administration 5% stake [FT]